- Home
- ALTG vs AARD Comparison
ALTG vs AARD Comparison
Compare ALTG & AARD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALTG
- AARD
- Stock Information
- Founded
- ALTG 1984
- AARD 2017
- Country
- ALTG United States
- AARD United States
- Employees
- ALTG N/A
- AARD N/A
- Industry
- ALTG Industrial Machinery/Components
- AARD Biotechnology: Pharmaceutical Preparations
- Sector
- ALTG Industrials
- AARD Health Care
- Exchange
- ALTG Nasdaq
- AARD Nasdaq
- Market Cap
- ALTG 206.7M
- AARD 231.9M
- IPO Year
- ALTG N/A
- AARD 2025
- Fundamental
- Price
- ALTG $5.89
- AARD $9.99
- Analyst Decision
- ALTG Hold
- AARD Strong Buy
- Analyst Count
- ALTG 3
- AARD 7
- Target Price
- ALTG $11.67
- AARD $31.43
- AVG Volume (30 Days)
- ALTG 141.3K
- AARD 176.4K
- Earning Date
- ALTG 11-06-2025
- AARD 11-13-2025
- Dividend Yield
- ALTG 3.81%
- AARD N/A
- EPS Growth
- ALTG N/A
- AARD N/A
- EPS
- ALTG N/A
- AARD N/A
- Revenue
- ALTG $1,851,100,000.00
- AARD N/A
- Revenue This Year
- ALTG $1.30
- AARD N/A
- Revenue Next Year
- ALTG $3.26
- AARD N/A
- P/E Ratio
- ALTG N/A
- AARD N/A
- Revenue Growth
- ALTG N/A
- AARD N/A
- 52 Week Low
- ALTG $3.54
- AARD $4.88
- 52 Week High
- ALTG $8.99
- AARD $19.58
- Technical
- Relative Strength Index (RSI)
- ALTG 35.75
- AARD 35.78
- Support Level
- ALTG $5.88
- AARD $10.57
- Resistance Level
- ALTG $6.15
- AARD $12.16
- Average True Range (ATR)
- ALTG 0.24
- AARD 0.85
- MACD
- ALTG -0.01
- AARD -0.36
- Stochastic Oscillator
- ALTG 5.31
- AARD 10.26
About ALTG Alta Equipment Group Inc.
Alta Equipment Group Inc is an integrated equipment dealership platform in the U.S. Its segments are Material Handling and Construction Equipment. The Material Handling segment is engaged in operations related to the sale, service, and rental of lift trucks in Michigan, Illinois, Indiana, New York, Virginia, and throughout the New England states whereas, the Construction Equipment segment is principally engaged in operations related to the sale, service, and rental of construction equipment in Michigan, Indiana, Illinois, Ohio, New York, Florida and throughout the New England States.
About AARD Aardvark Therapeutics Inc.
Aardvark Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases. It is focused on on developing selective compounds, targeting Bitter Taste Receptors (TAS2Rs) for hunger-associated conditions. Its product candidate, ARD-101, is an oral gut-restricted small-molecule agonist of certain TAS2Rs expressed in the gut lumen for which have initiated a Phase 3 clinical trial for hyperphagia associated with PWS.